Cigna Health Expected to Post Higher 4Q Profit, Revenue -- Earnings Preview

Dow Jones
02/05

By Connor Hart

 

Cigna Group is scheduled to report fourth-quarter results before the market opens Thursday. Here is what you need to know.

NET INCOME: The healthcare company is projected to post a profit of $1.74 billion, up from $1.42 billion a year earlier, according to analysts polled by FactSet.

ADJUSTED EARNINGS: Stripping out one-time items, earnings are expected to come in at $7.88 a share. That compares with adjusted earnings of $6.64 a share a year ago.

REVENUE: Quarterly revenue is forecast to be $70.31 billion, up from the $65.68 billion it notched last year.

Shares have climbed 7.1% over the past three months and were recently trading hands at $275.54.

WHAT TO WATCH

--While it has since pared back some of the loss, Cigna's stock dropped last quarter after the company warned the profits for its pharmacy-benefits business would likely be squeezed in 2026. The company attributed the pressure largely to renegotiated contracts with three major clients and costs associated with adopting an ambitious new payment model. Investors will be looking to see if these pressures have started to weigh on the unit's bottom line.

--The Trump administration last month proposed roughly flat rates for Medicare insurers next year, an update that fell well short of Wall Street expectations and triggered a brief selloff among healthcare stocks. The Medicare agency is also proposing to eliminate a lucrative industry billing practice that has raised concerns with government watchdogs. Investors will be eager to see if the company addresses these proposals, and the impact they could have on business.

 

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

February 04, 2026 13:25 ET (18:25 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10